Skip to main content
    S

    STERIS plc (STE)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NYSE

    $217.25
    -0.52 (-0.24%)

    Market Cap: $21.18B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    90%(35/39)
    Avg Surprise
    +4.39%
    Streak
    1 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$2.68
    Range$2.66 - $2.70
    8 analysts
    EPS RevisionsNo revisions (7d)
    0
    2
    30d
    EPS Estimate DriftChange to current
    90d ago$2.69-0.5%
    60d ago$2.70-0.7%
    30d ago$2.70-0.7%
    7d ago$2.69-0.3%
    Current$2.68
    Revenue Consensus
    $1.6B
    Range$1.6B - $1.6B
    9 analysts
    Period ending Dec 31, 2026
    EPS Consensus$2.81
    Range$2.77 - $2.83
    8 analysts
    EPS RevisionsNo revisions (7d)
    0
    4
    30d
    EPS Estimate DriftChange to current
    90d ago$2.81-0.0%
    60d ago$2.81-0.3%
    30d ago$2.81-0.3%
    7d ago$2.81-0.2%
    Current$2.81
    Revenue Consensus
    $1.6B
    Range$1.6B - $1.6B
    9 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Mar 27EST
    		-$3.20---
    Dec 26EST
    		-$2.81---
    Sep 26EST
    		-$2.68---
    Jun 26
    Reported Aug 5
    		$2.59$2.54+1.97%Beat+10.7%
    Mar 26
    Reported May 11
    		$2.83$2.85-0.70%Miss+3.3%
    Dec 25
    Reported Feb 4
    		$2.53$2.53+0.00%Beat+9.1%
    Sep 25
    Reported Nov 5
    		$2.47$2.38+3.78%Beat+15.4%
    Jun 25
    Reported Aug 6
    		$2.34$2.26+3.54%Beat+15.3%
    Mar 25
    Reported May 14
    		$2.74$2.60+5.38%Beat+6.2%
    Dec 24
    Reported Feb 5
    		$2.32$2.32+0.00%Beat+4.5%
    Sep 24
    Reported Nov 6
    		$2.14$2.13+0.47%Beat+3.4%
    Jun 24
    Reported Aug 6
    		$2.03$1.98+2.53%Beat+1.5%
    Mar 24
    Reported May 8
    		$2.58$2.41+7.05%Beat+12.2%
    Dec 23
    Reported Feb 7
    		$2.22$2.17+2.30%Beat+9.9%
    Sep 23
    Reported Nov 7
    		$2.07$2.00+3.50%Beat+4.0%
    Jun 23
    Reported Aug 1
    		$2.00$1.86+7.53%Beat+5.3%
    Mar 23
    Reported May 10
    		$2.30$2.15+6.98%Beat+12.7%
    Dec 22
    Reported Feb 8
    		$2.02$2.19-7.76%Miss-4.7%
    Sep 22
    Reported Nov 9
    		$1.99$1.98+0.51%Beat+0.0%
    Jun 22
    Reported Aug 2
    		$1.90$1.90+0.00%Beat+8.0%
    Mar 22
    Reported May 11
    		$2.04$2.02+0.99%Beat+25.2%
    Dec 21
    Reported Feb 8
    		$2.12$1.96+8.16%Beat+22.5%
    Sep 21
    Reported Nov 2
    		$1.99$1.82+9.34%Beat+34.5%
    Jun 21
    Reported Aug 9
    		$1.76$1.49+18.12%Beat+34.4%
    Mar 21
    Reported May 18
    		$1.63$1.80-9.44%Miss-0.6%
    Dec 20
    Reported Feb 2
    		$1.73$1.54+12.34%Beat+19.3%
    Sep 20
    Reported Nov 2
    		$1.48$1.27+16.54%Beat+12.1%
    Jun 20
    Reported Aug 3
    		$1.31$0.98+33.67%Beat+6.5%
    Mar 20
    Reported May 13
    		$1.64$1.58+3.80%Beat+7.2%
    Dec 19
    Reported Feb 10
    		$1.45$1.42+2.11%Beat+15.1%
    Sep 19
    Reported Nov 4
    		$1.32$1.25+5.60%Beat+20.0%
    Jun 19
    Reported Aug 5
    		$1.23$1.11+10.81%Beat+23.0%
    Mar 19
    Reported May 13
    		$1.53$1.43+6.99%Beat+23.4%
    Dec 18
    Reported Feb 11
    		$1.26$1.25+0.80%Beat+12.5%
    Sep 18
    Reported Nov 6
    		$1.10$1.09+0.92%Beat+17.0%
    Jun 18
    Reported Aug 8
    		$1.00$0.99+1.01%Beat+17.6%
    Mar 18
    Reported May 9
    		$1.24$1.22+1.64%Beat+11.7%
    Dec 17
    Reported Feb 7
    		$1.12$1.07+4.67%Beat+14.3%
    Sep 17
    Reported Nov 1
    		$0.94$0.94+0.00%Beat-
    Jun 17
    Reported Aug 8
    		$0.85$0.80+6.25%Beat-
    Mar 17
    Reported May 9
    		$1.11$1.06+4.72%Beat-
    Dec 16
    Reported Feb 7
    		$0.98$1.03-4.85%Miss-

    Dividends

    Dividend Metrics

    Forward Yield1.27%
    Forward Annual Dividend$2.76
    Payout Ratio19.52%
    FrequencyQuarterly
    Pay MonthsMar, Jun, Sep, Dec

    Growth

    3Y CAGR+10.06%
    5Y CAGR+9.28%
    STE dividend history and ex-dividend datesRun STE in the free DRIP calculator

    Key Metrics

    Valuation
    P/E Ratio20.85EV/EBITDA13.84x
    Price/FCF22.88xFCF Yield4.37%
    Profitability
    Profit Margin13.30%Operating Margin19.20%
    ROE11.40%ROIC9.26%
    Financial Health
    Debt/Equity0.28xInterest Coverage18.97x
    Current Ratio1.91xQuick Ratio1.35x
    Trading Statistics
    Beta0.93Avg Volume677.91K
    52-Week High$267.1452-Week Low$193.97

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$212.64
    SMA 20$210.73
    SMA 50$221.38
    SMA 200$225.78
    EMA 10$214.01
    EMA 20$213.65
    EMA 50$216.63
    EMA 200$223.64

    MACD

    Line: -0.68Signal: -2.36Hist: 1.68

    ADX

    ADX: 23.2+DI: 24.3-DI: 14.4

    Aroon & PSAR

    Aroon Up96.0
    Aroon Down32.0
    PSAR$212.29

    Bollinger Bands

    Upper Band$218.01
    Lower Band$203.45
    %B Position691%(Upper)
    Band Width0.95

    RSI (14-Day)

    Neutral
    55.8

    Momentum Oscillators

    Stoch %K78.3
    Stoch %D81.9
    Williams %R-28.2
    ROC (10d)3.4%
    Momentum7.24
    CCI (20d)186.6
    MFI (14d)56.8

    Volatility Measures

    ATR (14d)$4.54(2.1%)
    StdDev (20d)3.64
    Hist Vol15.1%(Low)

    Volume Flow

    VWAP$217.42
    OBV1.8M
    AD Line-106.0M
    CMF (20d)0.025

    Volume Metrics

    Avg Vol (20d)674.8K
    Vol Ratio0.9x
    VWMA (20d)$210.19

    Pivot Points

    R3$226.08
    R2$223.77
    R1$220.77
    Pivot Point$218.45
    S1$215.45
    S2$213.14
    S3$210.14

    Advanced Oscillators

    TSI-5.82
    Ultimate Osc54.6
    KST-38.75

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.49B$1.59B$1.50B$1.46B$1.39B$1.48B$1.37B$1.33B$1.28B$1.42B$1.30B$1.24B
    Cost of Revenue$808.60M$891.20M$840.70M$814.40M$763.10M$839.40M$760.20M$750.10M$707.10M$836.44M$737.70M$691.98M
    Gross Profit$684.20M$697.10M$655.50M$645.90M$628.00M$641.30M$610.30M$578.80M$572.40M$582.94M$560.03M$546.23M
    Operating Expenses$398.30M$380.40M$382.20M$380.10M$382.00M$425.10M$365.00M$359.10M$386.90M$362.53M$333.56M$354.68M
    R&D$28.60M$28.80M$29.50M$28.20M$26.40M$27.60M$27.40M$27.00M$25.60M$27.48M$25.25M$26.27M
    SG&A$369.70M$351.90M$352.30M$349.70M$353.80M$333.90M$335.50M$329.30M$335.60M$309.05M$308.30M$328.43M
    Operating Income$285.80M$316.80M$273.20M$265.80M$246.00M$216.10M$245.30M$219.70M$185.50M$220.32M$226.47M$191.55M
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$15.80M$15.00M$14.90M$14.90M$15.90M$17.10M$19.10M$19.70M$30.40M$36.16M$38.95M$36.94M
    Income Before Tax$273.50M$304.50M$257.80M$253.10M$231.90M$197.40M$228.70M$194.90M$175.20M$190.56M$189.60M$155.85M
    Income Tax Expense$72.50M$84.20M$63.50M$60.60M$53.90M$50.50M$55.40M$43.50M$35.30M$37.25M$41.00M$35.05M
    Net Income$201.00M$220.30M$194.30M$192.50M$178.00M$146.10M$173.30M$151.20M$145.50M$-981,000$140.94M$116.35M
    EBITDA$413.00M$442.90M$394.80M$389.70M$367.20M$336.80M$373.60M$329.90M$318.30M$361.09M$369.18M$345.04M
    EBIT$289.20M$319.50M$272.80M$268.00M$247.80M$214.50M$247.70M$214.60M$205.60M$226.62M$228.55M$192.79M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about STE

    Government Contracts

    Gov Obligations (TTM)
    $32.25M
    Gov Obligations / Revenue
    0.5%
    Obligations YoY
    -15.6%
    Active Awards
    1,888
    New Awards (TTM)
    1,696
    Avg Remaining Term
    7.4 mo

    Top agency: Department of Veterans Affairs at 68.1% of trailing twelve month obligations across 6 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    W81K0425PA045Department of DefenseDepartment of the Army$1.96MSep 30, 2025
    36C26226P1240Department of Veterans AffairsDepartment of Veterans Affairs$1.60MAug 1, 2026
    36C26325N0760Department of Veterans AffairsDepartment of Veterans Affairs$1.50MSep 1, 2025
    36C26226P0496Department of Veterans AffairsDepartment of Veterans Affairs$1.15MFeb 27, 2026
    36C25226F0314Department of Veterans AffairsDepartment of Veterans Affairs$816695Jun 11, 2026
    36C26325F0108Department of Veterans AffairsDepartment of Veterans Affairs$727222Sep 1, 2025
    36C25526P0098Department of Veterans AffairsDepartment of Veterans Affairs$562441Feb 19, 2026
    36C25526P0097Department of Veterans AffairsDepartment of Veterans Affairs$535412Feb 23, 2026
    36C26026P0183Department of Veterans AffairsDepartment of Veterans Affairs$503949Mar 1, 2026
    1232SA25C0025Department of AgricultureAgricultural Research Service$490718Sep 1, 2025

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Reasons to Add STE Stock to Your Portfolio Right Now

    STERIS plc (STE) is recommended as a stock to add to portfolios due to strong performance in its Healthcare and Applied Sterilization Technologies (AST) segments. The company is benefiting from increased demand...

    TradingView•10/16/26•Bullish

    STERIS plc $STE Stock Sold by Sustainable Growth Advisers LP

    Sustainable Growth Advisers LP reduced its stake in STERIS plc by 36.6% in the third quarter, selling 137,485 shares but still holding 237,752 shares valued at approximately $49.9 million. Despite this...

    MarketBeat•10/16/26•Somewhat-Bullish

    STERIS plc (Ireland) (STE) Stock Forecasts

    Argus has raised its target price for STERIS plc (Ireland) (STE) to $232.00. STERIS is a medical technology company specializing in sterilization services and infection prevention...

    Yahoo! Finance Canada•10/16/26•Bullish

    STERIS plc (Ireland) (STE) Stock Forecasts

    The article "STERIS plc (Ireland) (STE) Stock Forecasts" appears to be a stub or an error page from Yahoo Finance. It displays navigation elements, market data, and copyright information...

    Yahoo! Finance Canada•10/16/26•Neutral

    A Look at Steris PLC (STE) After 3.2% Gain -- GF Value $268.66 v

    Steris PLC (STE) shares recently rose 3.2% but are still down 10.8% year-to-date. The stock is currently trading at $224.33, which is 16.5% below its GF Value of $268.66...

    GuruFocus•10/15/26•Bullish

    STE Valuation and Fair Value

    P/E
    20.8x
    Forward P/E
    19.2x
    EV/EBITDA
    13.8x
    P/FCF
    22.9x
    PEG
    1.7x
    P/B
    2.9x
    See GNG's fair value

    STE Profitability: Margins, ROIC and FCF

    Gross margin
    44.4%
    Operating margin
    19.2%
    Net margin
    13.3%
    ROIC
    9.3%
    ROE
    11.4%
    FCF margin
    15.3%
    FCF yield
    4.4%

    STE Competitors

    CompanyTicker
    Insmed IncINSM
    Viatris IncVTRS
    Tenet Healthcare CorporationTHC
    EXACT Sciences CorporationEXAS
    Incyte CorporationINCY
    Zimmer Biomet Holdings IncZBH
    Genmab ASGMAB
    Hologic IncHOLX

    Sector: Healthcare

    STE Analyst Ratings

    Consensus
    Buy
    Analysts
    9
    Strong Buy
    3
    Buy
    4
    Hold
    2
    Sell
    0
    Strong Sell
    0

    STE Bull Case vs Bear Case

    Bull case

    • STE converts 15.3% of revenue into free cash flow.
    • 77.8% of STE's analyst ratings are Buy or Strong Buy.

    STE Earnings: Beat Rate and Next Report

    Beat rate
    5 of 8 quarters (62.5%)
    Average surprise
    1.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $2.68
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 2 down

    STE Dividend

    Forward yield
    1.3%
    Payout ratio
    19.5%
    3Y DPS growth
    10.1%
    5Y DPS growth
    9.3%
    Pay months
    Mar, Jun, Sep, Dec
    STE dividend history

    Frequently Asked Questions About STE

    What is STE's current dividend yield?

    STERIS plc (STE) has a forward dividend yield of 1.27%.

    Does STE pay dividends?

    Yes, STERIS plc pays dividends with a forward dividend yield of 1.27%.

    What is STE's P/E ratio?

    STERIS plc has a price-to-earnings (P/E) ratio of 20.85.

    What is STE's market cap?

    STERIS plc (STE) has a market capitalization of $21.18B with a current stock price of $217.25.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In